Annual report pursuant to Section 13 and 15(d)

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? DEFICIT (Details)

v3.24.1.1.u2
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (Details) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Increase (Decrease) in Stockholders' Equity                              
Beginning balance $ (101,931) $ (94,433) $ (91,321) $ (84,369) $ (77,963) $ (82,535) $ (76,500) $ (143,739) $ (84,369) $ (143,739) $ (84,369) $ (143,739) $ (84,369) $ (143,739) $ (199,936) [1]
Beginning balance (in shares) 95,850     93,574 93,144   90,606 60,433 93,574 60,433 93,574 60,433 93,574 60,433  
Net income (loss) $ (18,943) (9,869) (3,331) $ (9,142) $ (10,176) 113 $ (7,424) $ (879) $ (12,473) $ (8,303) $ (22,342) $ (8,190) $ (41,286) $ (18,368) 38,355
Foreign currency translation adjustments, net   1,465 (720) 249   $ 1,480 (1,298) (1,276) (471) (2,574) 994 (1,094) (612) (158) (567)
Shares issued under employee stock purchase plan                           897 1,762
Shares issued under employee incentive plans, net   0 0                   0 0 0
Shares issued in connection with rights offering, net                           66,249  
Shares issued in connection with business acquisition                           0 2,818
Deemed dividend on warrants             0 $ 0   0   $ 0   0  
Stock-based compensation   $ 906 939           2,831   $ 3,737   $ 4,720 $ 10,750 $ 13,829
Ending balance (in shares) 95,850 95,850     93,574 93,144   90,606     95,850 93,144 95,850 93,574 60,433
Ending balance $ (121,498) $ (101,931) (94,433) (91,321) $ (84,369) $ (77,963) (82,535) $ (76,500) (94,433) (82,535) $ (101,931) $ (77,963) $ (121,498) $ (84,369) $ (143,739)
As previously reported                              
Increase (Decrease) in Stockholders' Equity                              
Beginning balance     (94,080) (86,888) (77,053) (79,342) (68,787) (126,683) (86,888) (126,683) (86,888) (126,683) (86,888) (126,683) (112,245)
Net income (loss)       (10,576)   (2,170) (11,944) (10,220)   (22,164)   (24,334)   (37,943) (32,280)
Foreign currency translation adjustments, net       249   1,480 (1,298) (1,276)   (2,574)   (1,094)   (158) (567)
Shares issued under employee stock purchase plan                           897 1,762
Shares issued under employee incentive plans, net                             0
Shares issued in connection with rights offering, net                           66,249  
Shares issued in connection with business acquisition                             2,818
Settlement of warrant down round provision                           389  
Deemed dividend on warrants             0 (389)   (389)   (389)   (389)  
Stock-based compensation                           10,750 13,829
Ending balance       (94,080) (86,888) (77,053) (79,342) (68,787)   (79,342)   (77,053)   (86,888) (126,683)
Adjustments                              
Increase (Decrease) in Stockholders' Equity                              
Beginning balance     2,759 2,519 (910) (3,193) (7,713) (17,056) 2,519 (17,056) 2,519 (17,056) 2,519 (17,056) (87,691)
Net income (loss)       1,434   2,283 4,520 9,341   13,861   16,144   19,575 70,635
Foreign currency translation adjustments, net       0   0 0 0   0   0   0 0
Deemed dividend on warrants             0 389   389   389   389  
Ending balance       2,759 2,519 (910) (3,193) (7,713)   (3,193)   (910)   2,519 (17,056)
Common Stock                              
Increase (Decrease) in Stockholders' Equity                              
Beginning balance $ 959 $ 956 $ 938 $ 936 $ 932 $ 922 $ 907 $ 605 $ 936 $ 605 $ 936 $ 605 $ 936 $ 605 $ 570 [1]
Beginning balance (in shares) 95,850 95,519 93,705 93,574 93,144 92,158 90,606 60,433 93,574 60,433 93,574 60,433 93,574 60,433 56,915 [1]
Shares issued under employee stock purchase plan                           $ 6 $ 4
Shares issued under employee stock purchase plan (in shares)                           600 389
Shares issued under employee incentive plans, net   $ 3 $ 18           $ 20   $ 23   $ 23 $ 21 $ 23
Shares issued under employee incentive plans, net (in shares)   331 1,814           1,945   2,276   2,276 2,180 2,308
Shares issued in connection with rights offering, net                           $ 300  
Shares issued in connection with rights offering, net (in shares)                           30,000  
Shares issued in connection with business acquisition                           $ 4 $ 8
Shares issued in connection with business acquisition (in shares)                           361 821
Ending balance (in shares) 95,850 95,850 95,519 93,705 93,574 93,144 92,158 90,606 95,519 92,158 95,850 93,144 95,850 93,574 60,433
Ending balance $ 959 $ 959 $ 956 $ 938 $ 936 $ 932 $ 922 $ 907 $ 956 $ 922 $ 959 $ 932 $ 959 $ 936 $ 605
Common Stock | As previously reported                              
Increase (Decrease) in Stockholders' Equity                              
Beginning balance       $ 936       $ 605 $ 936 $ 605 $ 936 $ 605 $ 936 $ 605 $ 570
Beginning balance (in shares)       93,574       60,433 93,574 60,433 93,574 60,433 93,574 60,433 56,915
Shares issued under employee stock purchase plan                           $ 6 $ 4
Shares issued under employee stock purchase plan (in shares)                           600 389
Shares issued under employee incentive plans, net                           $ 21 $ 23
Shares issued under employee incentive plans, net (in shares)                           2,180 2,308
Shares issued in connection with rights offering, net                           $ 300  
Shares issued in connection with rights offering, net (in shares)                           30,000  
Shares issued in connection with business acquisition                           $ 4 $ 8
Shares issued in connection with business acquisition (in shares)                           361 821
Ending balance (in shares)         93,574                 93,574 60,433
Ending balance         $ 936                 $ 936 $ 605
Additional Paid-in Capital                              
Increase (Decrease) in Stockholders' Equity                              
Beginning balance 706,133 705,230 704,309 $ 702,370 699,536 696,567 693,896 $ 624,805 $ 702,370 $ 624,805 $ 702,370 $ 624,805 $ 702,370 624,805 606,431 [1]
Shares issued under employee stock purchase plan                           891 1,758
Shares issued under employee incentive plans, net   (3) (18)           (20)   (23)   (23) (21) (23)
Shares issued in connection with rights offering, net                           65,949  
Shares issued in connection with business acquisition                           (4) 2,810
Stock-based compensation   906 939           2,831   3,737   4,720 10,750 13,829
Ending balance 707,116 706,133 705,230 704,309 702,370 699,536 696,567 693,896 705,230 696,567 706,133 699,536 707,116 702,370 624,805
Additional Paid-in Capital | As previously reported                              
Increase (Decrease) in Stockholders' Equity                              
Beginning balance       722,603       645,038 722,603 645,038 722,603 645,038 722,603 645,038 626,664
Shares issued under employee stock purchase plan                           891 1,758
Shares issued under employee incentive plans, net                           (21) (23)
Shares issued in connection with rights offering, net                           65,949  
Shares issued in connection with business acquisition                           (4) 2,810
Settlement of warrant down round provision                           389  
Deemed dividend on warrants                           (389)  
Stock-based compensation                           10,750 13,829
Ending balance         722,603                 722,603 645,038
Additional Paid-in Capital | Adjustments                              
Increase (Decrease) in Stockholders' Equity                              
Beginning balance       (20,233)       (20,233) (20,233) (20,233) (20,233) (20,233) (20,233) (20,233) (20,233)
Ending balance         (20,233)                 (20,233) (20,233)
Accumulated Deficit                              
Increase (Decrease) in Stockholders' Equity                              
Beginning balance (808,436) (798,567) (795,236) (786,094) (775,914) (776,027) (768,604) (767,726) (786,094) (767,726) (786,094) (767,726) (786,094) (767,726) (806,081) [1]
Net income (loss)   (9,869) (3,331)           (12,473)   (22,342)   (41,286) (18,368) 38,355
Ending balance (827,380) (808,436) (798,567) (795,236) (786,094) (775,914) (776,027) (768,604) (798,567) (776,027) (808,436) (775,914) (827,380) (786,094) (767,726)
Accumulated Deficit | As previously reported                              
Increase (Decrease) in Stockholders' Equity                              
Beginning balance       (808,846)       (770,903) (808,846) (770,903) (808,846) (770,903) (808,846) (770,903) (738,623)
Net income (loss)                           (37,943) (32,280)
Ending balance         (808,846)                 (808,846) (770,903)
Accumulated Deficit | Adjustments                              
Increase (Decrease) in Stockholders' Equity                              
Beginning balance       22,752       3,177 22,752 3,177 22,752 3,177 22,752 3,177 (67,458)
Net income (loss)                           19,575 70,635
Ending balance         22,752                 22,752 3,177
Accumulated Other Comprehensive Loss                              
Increase (Decrease) in Stockholders' Equity                              
Beginning balance (587) (2,052) (1,332) (1,581) (2,517) (3,997) (2,699) (1,423) (1,581) (1,423) (1,581) (1,423) (1,581) (1,423) (856) [1]
Foreign currency translation adjustments, net   1,465 (720)           (471)   994   (612) (158) (567)
Ending balance $ (2,193) $ (587) $ (2,052) (1,332) (1,581) $ (2,517) $ (3,997) (2,699) (2,052) (3,997) (587) (2,517) (2,193) (1,581) (1,423)
Accumulated Other Comprehensive Loss | As previously reported                              
Increase (Decrease) in Stockholders' Equity                              
Beginning balance       $ (1,581)       $ (1,423) $ (1,581) $ (1,423) $ (1,581) $ (1,423) $ (1,581) (1,423) (856)
Foreign currency translation adjustments, net                           (158) (567)
Ending balance         $ (1,581)                 $ (1,581) $ (1,423)
[1] The March 31, 2021 ending total shareholders’ deficit reflects the impact of the restatement totaling $87.7 million related to SSP and warrant classification adjustments prior to that time, including a $67.5 million increase of Accumulated deficit and a $20.2 million decrease of Additional paid-in -capital.